Publications

Dernière publication 21/03/2021

Triptolide prevents lipopolysaccharide_induced skeletal muscle atrophy via inhib

Background and Purpose Increasing evidence suggests systemic inflammation-caused skeletal muscle atrophy as a major clinical feature of cachexia....

Array
(
    [id_prestablog_news] => 1396
    [id_shop] => 1
    [date] => 2021-03-21 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 3013
    [id_lang] => 2
    [title] => Triptolide prevents lipopolysaccharide_induced skeletal muscle atrophy via inhib
    [paragraph] => Triptolide prevents lipopolysaccharide_induced skeletal muscle atrophy via inhibiting NF__B and TNF__ and regulating protein synthesis and degradation pathway
    [content] => 
Authors
WY Fang, YT Tseng, TY Lee et al

 Lab
Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 80708, Taiwan.
Journal
British Journal of Pharmacology
Abstract
Background and Purpose Increasing evidence suggests systemic inflammation-caused skeletal muscle atrophy as a major clinical feature of cachexia. Triptolide obtained from Tripterygium wilfordii Hook F possesses potent anti-inflammatory and immunosuppressive effects. The present study aims to evaluate the protective effects and molecular mechanisms of triptolide on inflammation-induced skeletal muscle atrophy.
Experimental Approach The effects of triptolide on skeletal muscle atrophy were investigated in LPS-treated C2C12 myotubes and C57BL/6 mice. Protein expressions and mRNA levels were analysed by western blot and qPCR, respectively. Skeletal muscle mass, volume and strength were measured by histological analysis, micro-CT and grip strength, respectively. Locomotor activity was measured using the open field test.
KEY RESULTS Triptolide (10–100_fM) up-regulated protein synthesis signals (IGF-1/p-IGF-1R/IRS-1/p-Akt/p-mTOR) and down-regulated protein degradation signal atrogin-1 in C2C12 myotubes. In LPS (100_ng·ml_1)-treated C2C12 myotubes, triptolide up-regulated MyHC, IGF-1, p-IGF-1R, IRS-1 and p-Akt. Triptolide also down-regulated ubiquitin-proteasome molecules (n-FoxO3a/atrogin-1/MuRF1), proteasome activity, autophagy-lysosomal molecules (LC3-II/LC3-I and Bnip3) and inflammatory mediators (NF-_B, Cox-2, NLRP3, IL-1beta and TNF-alpha). However, AG1024, an IGF-1R inhibitor, suppressed triptolide-mediated effects on MyHC, myotube diameter, MuRF1 and p62 in LPS-treated C2C12 myotubes. In LPS (1 mg·kg_1, i.p.)-challenged mice, triptolide (5 and 20_microg·kg_1·day_1, i.p.) decreased plasma TNF-_ levels and it increased skeletal muscle volume, cross-sectional area of myofibers, weights of the gastrocnemius and tibialis anterior muscles, forelimb grip strength and locomotion.
Conclusions and Implications These findings reveal that triptolide prevented LPS-induced inflammation and skeletal muscle atrophy and have implications for the discovery of novel agents for preventing muscle wasting.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)

Keywords/Topics
Inflammation; Atrophie musculaire
    [meta_description] => 
    [meta_keywords] => https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.15472
    [meta_title] => 
    [link_rewrite] => triptolide-prevents-lipopolysaccharideinduced-skeletal-muscle-atrophy-via-inhibiting-nfb-and-tnf-and-regulating-protein-synthesis-and-degradation-pathway
    [actif_langue] => 1
    [read] => 898
    [count_comments] => 0
    [id] => 1396
    [categories] => Array
        (
            [65] => Array
                (
                    [id_prestablog_categorie] => 65
                    [title] => Atrophie musculaire
                    [link_rewrite] => Atrophie-musculaire
                )

            [93] => Array
                (
                    [id_prestablog_categorie] => 93
                    [title] => Inflammation
                    [link_rewrite] => Inflammation
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Triptolide prevents lipopolysaccharide_induced skeletal muscle atrophy via inhibiting NF__B [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Test d'agrippement
                    [description_short] => 
Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
                )

        )

)
1